New TSRI Metabolomic Platform Reveals Fundamental Flaw in Common Lab TechnologyA technology used in thousands of labs fundamentally alters the samples it analyzes.
Team Identifies Potential Target for Individualized Treatment of Autism Spectrum DisorderA grant of $2.4 million will support further research.
Researchers Identify Promising Drug Candidate to Treat Chronic Itch that Avoids Side EffectsThe team refined an aspect of signaling at the receptor to avoid sedation.
Scientists Identify a Key Morphine Regulator that May Reduce Risk of Pain-Killer Abuse and AddictionThe findings could lead to a new drug target for developing less-addictive pain medications.
Study Identifies Novel Role of Mitochondria in Immune FunctionThe findings reveal new targets for treating cancer and autoimmune diseases.
Researchers Awarded $6 Million to Develop Alternative HIV/AIDS Vaccine"I'm grateful to the Gates Foundation for its strong support of our research and for its continued commitment to eradicating HIV/AIDS throughout the world," says Professor Michael Farzan.
Scripps Research Institute Names Peter Schultz as CEO, Steve Kay as President"Their shared vision of creating a unique position for the Institute at the forefront of basic and translational research is tremendously exciting," says Dick Gephardt, Chair of the TSRI Board of Trustees.
TSRI and UC San Diego Launch New Consortium to Create 'Virtual Cell'The collaboration has a big mission: to map cells in space and time.
Scripps Research Institute Receives $5.65 Million Gift from Philanthropist Helen DorrisThe new gift will enhance the endowment for TSRI’s Dorris Neuroscience Center.
Institute Receives $12.5 Million Challenge Gift The gift from an anonymous donor anchors the construction funding for a new building complex on the Scripps California campus.